This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Data availability
The data that support the findings of this study are available from the corresponding author upon reasonable request.
References
Khwaja A, Bjorkholm M, Gale RE, Levine RL, Jordan CT, Ehninger G, et al. Acute myeloid leukaemia. Nat Rev Dis Primers. 2016;2:16010.
DiNardo CD, Erba HP, Freeman SD, Wei AH. Acute myeloid leukaemia. Lancet. 2023;401(2073):86.
Feng M, Xie X, Han G, Zhang T, Li Y, Li Y, et al. YBX1 is required for maintaining myeloid leukemia cell survival by regulating BCL2 stability in an m6A-dependent manner. Blood. 2021;138:71–85.
Perner F, Schnoeder TM, Xiong Y, Jayavelu AK, Mashamba N, Santamaria NT, et al. YBX1 mediates translation of oncogenic transcripts to control cell competition in AML. Leukemia. 2022;36:426–37.
Xu JJ, Ji L, Liang YL, Wan Z, Zheng W, Song XM, et al. CircRNA-SORE mediates sorafenib resistance in hepatocellular carcinoma by stabilizing YBX1. Signal Transduct Tar. 2020;5:298.
Lange SM, Armstrong LA, Kulathu Y. Deubiquitinases: From mechanisms to their inhibition by small molecules. Mol Cell. 2022;82:15–29.
Yu M, Fang ZX, Wang WW, Zhang Y, Bu ZL, Liu M, et al. Wu-5, a novel USP10 inhibitor, enhances crenolanib-induced FLT3-ITD-positive AML cell death via inhibiting FLT3 and AMPK pathways. Acta Pharmacol Sin. 2021;42:604–12.
Lei H, Xu HZ, Shan HZ, Liu M, Lu Y, Fang ZX, et al. Targeting USP47 overcomes tyrosine kinase inhibitor resistance and eradicates leukemia stem/progenitor cells in chronic myelogenous leukemia. Nat Commun. 2021;12:51.
Cartel M, Mouchel PL, Gotanegre M, David L, Bertoli S, Mansat-De Mas V, et al. Inhibition of ubiquitin-specific protease 7 sensitizes acute myeloid leukemia to chemotherapy. Leukemia. 2021;35:417–32.
Lei H, Yang L, Wang Y, Zou Z, Liu M, Xu H, et al. JOSD2 regulates PKM2 nuclear translocation and reduces acute myeloid leukemia progression. Exp Hematol Oncol. 2022;11:42.
Acknowledgements
This work was supported in part by grants from the National Natural Science Foundation of China (82170145, 81700475); CAMS Innovation Fund for Medical Sciences (CIFMS): 2019-I2M-5-051; Shanghai Municipal Commission of Health and Family Planning, NO. ZY (2021-2023)-0208; We thank the support from Shanghai Frontiers Science Center of Cellular Homeostasis and Human Diseases.
Author information
Authors and Affiliations
Contributions
The experiments were conceived and designed by HL and YW. The plasmids were constructed by HL and HX. HL performed animal experiments. The AML patient samples were collected by HL, LY, YZ and YW. The paper was written and revised by HL.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
About this article
Cite this article
Lei, H., Xu, H., Yang, L. et al. USP47 stabilizes YBX1 to promote the progression of acute myeloid leukemia. Oncogene 43, 539–542 (2024). https://doi.org/10.1038/s41388-023-02921-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41388-023-02921-1